Zusammenfassung
Viele Patienten, die operiert oder intensivmedizinisch betreut werden müssen, nehmen Medikamente ein, deren Kenntnis für die Anästhesie und Intensivmedizin von Bedeutung ist. Manche Pharmaka sollten vor Operationen abgesetzt oder in der Dosierung besonders eingestellt werden (► Abschn. 14.14), andere können mit Anästhetika interferieren. Dieses Kapitelsoll daher eine Übersicht über solche Arzneistoffe geben, die in der Dauermedikation besonders zu beachten sind oder die als perioperative Adjuvanzien Verwendung finden (praktische Anwendung ► Kap. 25).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
ALLHAT Investigators (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihyper-tensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981–2997
Despotis G, Eby C, Lublin DM (2008) A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery. Transfusion 48:2S–30S
Fishbane S (2008) N-acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol 3:281–287
Habib AS, Gan TJ (2003) Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 96:1377–1379
Kozer E, Koren G (2001) Management of paracetamol overdose: current controversies. Drug Saf 24:503–512
Ledingham IM, Watt I (1983) Influence of sedation on mortality in critically ill multiple trauma patients [letter]. Lancet 1:1270
Lecompte T, Hardy JF (2006) Antiplatelet agents and perioperative bleeding. Can J Anaesth 53: S103–S112
Martin J, Heymann A, Basell K et al. (2010) Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care-short version. Ger Med Sci 8: Doc02
Patrono C, CoIIer B, FitzGerald GA et al. (2004) Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:234S#x2013;264S
Sprung CL, Annane D, Keh D et al. (2008) Hydrocortisone therapy for patients with septic shock. N EngI J Med 358:111–124
Steffel J, LuscherTF, Ruschitzka F,Tanner FC (2006) Cyclooxygenase-2 inhibition and coagulation. J Cardiovasc Pharmacol 47 Suppl1:S15–20
Van de Werf F, Bax J, Betriu A et al. (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29:2909–2945
Weitz JI, Hirsh J, Samama MM (2008) New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:234S–256S
White PF (2002) Droperidol: a cost-effective antiemetic for over thirty years. Anesth Analg 95:789–790.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tonner, P.H., Hein, L. (2011). Dauermedikation und perioperative Adjuvanzien. In: Tonner, P.H., Hein, L. (eds) Pharmakotherapie in der Anästhesie und Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79156-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-540-79156-0_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79155-3
Online ISBN: 978-3-540-79156-0
eBook Packages: Medicine (German Language)